Highline Wealth Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
Highline Wealth Partners's BME Position: Q3 2026 in Review
Highline Wealth Partners sold out of BlackRock Health Sciences Trust (BME) in Q3 2026, closing a stake of 75 shares — an estimated $3.22K sold.
Highline Wealth Partners first reported a position in BME in Q1 2026 and held it in 2 quarters. The position peaked at $3.22K in Q2 2026. 21 funds tracked by Wall St. Rank hold BME as of Q3 2026.
- Highline Wealth Partners reported no remaining BlackRock Health Sciences Trust position as of Q3 2026 after selling out during the quarter.
- Highline Wealth Partners sold 75 BlackRock Health Sciences Trust shares in Q3 2026, an estimated $3.22K.
- Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust in Q1 2026 and held it in 2 quarters.
- Highline Wealth Partners's BlackRock Health Sciences Trust position peaked at $3.22K in Q2 2026.
- 21 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.